QD Quadramed Corp.

QuadraMed� Corporation (Amex:QD) today announced that Sandra Trakowski, MS, RN, BC, has been appointed Vice President, Clinical Product Management. Her responsibilities include strategic planning for and management of QuadraMed�s Care Management product suite. These applications provide a total solution to help healthcare organizations maximize clinician decision support for significantly improved patient safety and more efficient delivery of quality care. Ms. Trakowski joins QuadraMed from Care Fusion, Inc., McLean, Virginia, where she served more than three years as vice president of clinical products. Her other experience includes five years as associate director of nursing informatics at Washington Hospital Center in Washington, DC, and positions with TDS Healthcare Systems, the predecessor of Eclipsys, and the National Institutes of Health. Sandy Trakowski earned her Bachelor of Science degree in Nursing from George Mason University, and was awarded a Master of Sport Science, Sports Medicine from the United States Sports Academy. For information about all QuadraMed Care-Based Revenue Cycle� solutions and related services, visit www.quadramed.com or call 800.393.0278. About QuadraMed Corporation QuadraMed Corporation advances the success of healthcare organizations through IT solutions that leverage quality care into positive financial outcomes. Using QuadraMed�s Care-Based Revenue Cycle solutions, which are designed to optimize the patient experience and leverage quality of care into payment, our clients seek to receive the proper reimbursement, in the shortest time, at the lowest administrative cost. QuadraMed delivers real world solutions that help healthcare professionals deliver outstanding patient care with significant efficiency. Behind our products and services is a staff of 600 professionals whose experience and dedication to service have earned QuadraMed the trust and loyalty of customers at approximately 2,000 healthcare provider facilities. Cautionary Statement on Risks Associated with QuadraMed�s Forward-Looking Statements This press release contains forward-looking statements, as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, by QuadraMed that are subject to risks and uncertainties. The words "believe," "expect," "anticipate," "intend," "plan," "estimate," "may," "should," "could," and similar expressions are intended to identify such statements. Forward-looking statements are not guarantees of future performance and are to be interpreted only as of the date on which they are made. QuadraMed undertakes no obligation to update or revise any forward-looking statement except as required by law. QuadraMed advises investors that it discusses risk factors and uncertainties that could cause QuadraMed�s actual results to differ from forward-looking statements in its periodic reports filed with the Securities and Exchange Commission ("SEC"). QuadraMed�s SEC filings can be accessed through the Investor Relations section of our website, www.quadramed.com, or through the SEC�s EDGAR Database at www.sec.gov (QuadraMed has EDGAR CIK No. 0001018833). QuadraMed is a registered trademark of QuadraMed Corporation. All other trademarks are the property of their respective holders.